Columnists
Health
Technology
Home page
Arts/Entertainment
Business
Food
GuideLive
Health | Science
House & Garden
Lottery
Metro | Obituaries
National | World
Opinion
Photography
Politics
Religion
Sports Day
Technology
Texas Living
Texas & Southwest
Texas Legislature
Traffic
Travel
Weather
Classifieds
Jobs
Homes
Cars
Contact us
Site index
New
Sign up for MyNews

Receive headline news, full articles and breaking news via the Web or wireless device.

E-mail this page to a friend
Online extras
Specials area
Obesity: Science weighs in





DallasNews.com: Contact us DallasNews.com: Science
Injection an Alzheimer's first

Doctors hope genetically altered cells can slow mental decline

04/11/2001

Washington Post

Doctors in California have implanted genetically modified cells into the brain of a 60-year-old woman with an early stage of Alzheimer's disease in an effort to slow her mental decline, members of the research team announced Tuesday.

The experimental surgery, which researchers hope to test in seven other patients, represents the first trial of gene therapy for a degenerative brain disorder, said neuroscientist Mark Tuszynski, who leads the project.

The cells, obtained from the woman's skin, were equipped with a gene to produce nerve growth factor, a natural substance that promotes growth and survival of brain cells. The treatment is not expected to cure Alzheimer's disease, although studies in animals suggest that it may help preserve the recipients' capacity to learn and remember.

"We hope that we can keep people at a higher level of function for a longer time period," said Dr. Tuszynski, an associate professor of neurosciences at the University of California at San Diego and the VA Hospital.

But some experts expressed concern that if complications occur, they may be difficult to treat because there's no simple way to remove the genetically modified cells or stop their action once they've been implanted in the brain.

"It's quite aggressive," said Vassilis Koliatsos, an associate professor of pathology and neurology at Johns Hopkins School of Medicine. "Growth factors are extremely powerful compounds, and they're not selective for a particular brain system. ... We've got to be watching here."

Alzheimer's disease is a progressive brain disorder affecting 2 million to 4 million Americans. It gradually damages and destroys cells in many regions of the brain, eventually rendering its victims helpless. Current treatments produce only modest and short-lived improvement at best.

Doctors said the patient, a former teacher from Oregon whose name was not released, gave her consent to the experimental procedure. In an eleven-hour operation last Thursday, neurosurgeon Hoi Sang U and his team injected half a million genetically modified cells into each of five sites on the right side of her brain.

It may take several weeks before researchers can detect any possible effect on the woman's brain function and several years before they know whether the treatment is effective.









InteliHealth
Feature index
Ask the Doc
Drug database
Disease InfoFinder


Subscribe to The Dallas Morning News Classifieds.DallasNews.com Community.DallasNews.com DallasNews.com Archives

© 2001 The Dallas Morning News
Privacy policy
2000, 1999 Katie winner for best news-related Web site
1998, 1999 best online newspaper in the state Texas Associated Press Managing Editors Award
View contact information for each of our offices. This is where you will find a list of our agents also. Info

A number of snack vending machines are electrically operated. There are snack vending machines that are see-through or have fronts which are glass-made. Various snack vending machines can only dispense as little as six or ten types of snacks or it can sell a wide range of snack and beverage choices.